Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

<p>Kaplan–Meier curves by treatment. The red line represents the ICI–ICI group, and the blue line represents the ICI–TKI group.</p>

Saved in:

Bibliographic Details
Main Author:	Bunpei Isoda (22273897) (author)
Other Authors:	Masanobu Shiga (22273900) (author), Shuya Kandori (20806494) (author), Shota Takahashi (22273903) (author), Akifumi Omiya (22273906) (author), Tomoki Ishida (22273909) (author), Kotoe Matsuda (22273912) (author), Hiromichi Sakurai (22273915) (author), Bryan J. Mathis (20803922) (author), Ken Tanaka (22273918) (author), Manabu Komine (22273921) (author), Masahiro Iinuma (22273924) (author), Akira Joraku (22273927) (author), Hiromitsu Negoro (17411086) (author), Masakazu Tsutsumi (22273930) (author), Takamitsu Inoue (22273933) (author), Jun Miyazaki (22273936) (author), Hiroyuki Nishiyama (18287202) (author)
Published:	2025
Subjects:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Clinical Research and Trials Antibody Immunotherapy Cell Signaling Clinical-stage Research Genitourinary Cancers Renal cancer Immunotherapy Toxicities/irAEs Immune Cells And The Microenvironment Protein Tyrosine Kinases Tumor Microenvironment
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	<p>Kaplan–Meier curves by treatment. The red line represents the ICI–ICI group, and the blue line represents the ICI–TKI group.</p>